(ADPnews) - Feb 18, 2011 - Norwegian krill oil company Aker Biomarine ASA (OSL:AKBM) turned to a net profit of NOK 178 million (USD 31m/EUR 23m) in 2010 from a year-earlier loss of NOK 304 million, buoyed by a NOK-393-million gain on the sale of a stake in a unit.
'The year was Aker Biomarine's best so far,' the company said in its statement today.
RevenuesA more that doubled to NOK 311 million from NOK 141 million, as sales of krill oil, used for its health benefits, under the Superba brand tripled.
The company also reported for the first time positive earnings before interest, taxes, depreciation and amortisation (EBITDA), of NOK 20 million, versus a loss of NOK 130 million in 2009.
Aker Biomarine considers that it is well-positioned for further growth in all markets.
In November, the company completed the sale of a 50% stake in its subsidiary TryggA PharmaA Holding, owningA the unit NaturalA NutritionA DevelopmentA AS. The buyer is US private equity firm Lindsay Goldberg LLC.
(NOK 1.0 = USD 0.175/EUR 0.129)
0 comments:
Post a Comment